Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

UnitedHealth Boosts Earnings Forecast, Set to Pass Price Discounts to Patients

Tamara Mathias and Caroline Humer  |  July 22, 2019

The company’s medical care ratio, or the percentage of premiums paid out for medical services, worsened to 83.1%, from 81.9% a year earlier. Analysts had expected 83%.

Net earnings attributable to shareholders rose 12.7% to $3.29 billion, or $3.42 per share, in the three months ended June 30.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Excluding items, UnitedHealth earned $3.60 per share, beating the average analyst estimate of $3.45, according to IBES data from Refinitiv.

(Reporting by Caroline Humer in New York and Tamara Mathias and Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila and Bernadette Baum)

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

 

Page: 1 2 | Single Page
Share: 

Filed under:Uncategorized Tagged with:David Wichmanndrug maker discountsdrug pricingdrug rebateshealthcare costsUnitedHealth Group Inc.

Related Articles

    UnitedHealth Sees More Growth in 2017 When It Exits Obamacare

    October 18, 2016

    (Reuters)—UnitedHealth Group Inc, the largest U.S. health insurer, on Tuesday raised the possibility of stronger profit growth in 2017 as it exits the government-subsidized insurance market commonly known as Obamacare, encouraging investors who have been negative on the sector. The company said losses in that business were within expectations in the third quarter, news that…

    U.S. Accuses UnitedHealth of Medicare Advantage Fraud

    May 2, 2017

    (Reuters)—The U.S. Justice Department (DOJ) has accused UnitedHealth Group Inc. of obtaining inflated payments from the government based on inaccurate information about the health status of patients enrolled in its largest Medicare Advantage Plan.1 The complaint, filed in federal court in Los Angeles on Monday, came after the DOJ earlier this year intervened in two…

    New York Orders UnitedHealth to Pay $100,000 to Settle Antitrust Probe

    January 7, 2016

    WASHINGTON (Reuters)—The New York Attorney General has ordered UnitedHealth Group to pay a $100,000 fine after an investigation found the insurance provider engaged in anti-competitive practices involving elder and long-term care products, according to a person familiar with the matter. The settlement, which was signed late Wednesday, centers on efforts by UnitedHealth to force nursing…

    4 Steps to a More Efficient Healthcare Revenue Cycle in a Physician Practice

    November 16, 2016

    As the year draws to a close, it is vital to pay close attention to your practice’s revenue cycle to maintain an operational and financially healthy business. Operational aspects should be a top priority, with careful monitoring as they relate to efficiency in receivables and denials management. Healthcare revenue cycle management is the strategy that…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences